June 12, 2009
ACT: New Retinal Disease Treatments Promising
Worcester's Advanced Cell Technology Inc. says its recent studies offer promising data about stem cell therapy to combat retinal disease.
ACT says the research, which appears in the journal Stem Cells, demonstrates the potential of the new technology for age-related macular degeneration and Stargardt disease, an untreatable eye disease that leads to blindness.
Based partly on the studies, ACT said it plans to file an application with the FDA to begin human clinical trials sometime in the next three to four months.
WBJ Web Partners
Most Recent
Most Recent
0 Comments